Welcome to our dedicated page for Prestige Consumer Healthcare SEC filings (Ticker: PBH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Prestige Consumer Healthcare's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Prestige Consumer Healthcare's regulatory disclosures and financial reporting.
Prestige Consumer Healthcare Senior VP of Operations Jeffrey Zerillo reported an open-market sale of 305 shares of common stock at $54.36 per share. A separate transaction shows 351 shares withheld at $54.59 per share to cover tax obligations, a non-market event.
After these transactions, Zerillo directly holds 42,161 shares of Prestige Consumer Healthcare common stock, indicating that the reported sale represents only a small portion of his remaining stake.
Prestige Consumer Healthcare CFO & COO Christine Sacco reported a routine tax-related share disposition. On May 7, 991 shares of common stock were withheld at $54.59 per share to cover tax obligations, a non-market transaction. After this, she directly owns 71,636 shares of Prestige Consumer Healthcare common stock.
Prestige Consumer Healthcare Inc. Chief Executive Officer Ronald M. Lombardi reported a routine share withholding for taxes. On May 7, 2026, 2,543 shares of common stock were disposed of at $54.59 per share as a tax-withholding disposition, rather than an open-market sale. Following this transaction, Lombardi directly holds 373,465 shares of Prestige Consumer Healthcare common stock.
Prestige Consumer Healthcare EVP Mekhail Adel reported a routine tax-related share disposition. On May 7, 2026, 487 shares of common stock were withheld at $54.59 per share to cover tax obligations. After this transaction, Adel directly holds 25,703 shares of Prestige Consumer Healthcare common stock.
PBH Rule 144 notice filed to offer 351 shares of Common Stock. The filing shows 351 shares tied to Restricted Stock Vesting on 05/07/2026 and lists Fidelity Brokerage Services LLC as the broker. The record also lists recent sales by Jeffrey Zerillo totaling 2,858 shares across February and May 2026 with associated dollar figures shown in the excerpt.
Prestige Consumer Healthcare Senior VP Operations Jeffrey Zerillo reported an open-market sale of 1,207 shares of common stock at $54.99 per share. In a separate transaction, 307 shares were disposed of to satisfy tax withholding obligations at $55.75 per share. Following these transactions, he directly holds 44,027 shares after the tax-withholding disposition and 42,820 shares after the open-market sale, indicating these trades involved a relatively small portion of his reported direct holdings.
Prestige Consumer Healthcare CFO & COO Christine Sacco reported a tax-related share disposition. On May 5, 2026, 1,267 shares of common stock were withheld at $55.75 per share to cover tax obligations. After this non‑market transaction, she directly owned 72,627 shares of Prestige Consumer Healthcare common stock.
Prestige Consumer Healthcare Inc. Chief Executive Officer Ronald M. Lombardi reported a routine tax-related share disposition. On the reported date, 2,197 shares of common stock were delivered at $55.75 per share to satisfy a tax liability. Following this tax-withholding disposition, he directly holds 376,008 shares of Prestige Consumer Healthcare common stock.
PBH reports a Form 144 filing for the proposed sale of 305 shares of Common Stock linked to restricted stock vesting on 05/05/2026. The filing also lists recent sales by Jeffrey A. Zerillo: 1,000 shares on 02/11/2026, 346 shares on 05/05/2026, and 1,207 shares on 05/06/2026.
Prestige Consumer Healthcare Inc. reported that CFO & COO Christine Sacco received equity compensation and related tax withholding transactions in company stock. She acquired 11,976 shares of common stock upon settlement of performance stock units granted on May 5, 2023, which vested on May 4, 2026 based on per share growth goals. She also received a 7,008‑share restricted stock award that vests in three equal installments of 3,992 shares on May 4, 2027, May 4, 2028 and May 4, 2029. To cover tax obligations, 3,434 shares were withheld at $55.31 per share. After these transactions, she directly holds 61,918 shares of Prestige Consumer Healthcare common stock.